Reyataz

Licence status
Authorised: 17/04/2008
Active substances
Atazanavir sulfate
Dosage Form
Capsule, hard
Licence number
EU/1/03/267/8-9
Licence holder
Bristol-Myers Squibb Pharma EEIG

Product documents

Licence information

ATC code
J05AE Protease inhibitors, J05AE08 atazanavir
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
17/04/2008

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie